Description

Expiring patents on revenue generating drugs, competition from generic drugs and increasing research and development cost, is forcing pharmaceutical manufacturers to often outsource drug discovery processes. Over the years pharmaceutical outsourcing has moved up the value chain from non core functions to even core functions. The segment gives an overview of global drug discovery outsourcing trends. In addition, it discusses in detail the current scenario and growth opportunity areas in some of the leading outsourcing locations in the world namely China, India, Brazil, Mexico, Russia and Poland.